Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

3 structures for Q96D31

Entry ID Method Resolution Chain Position Source
2MAK NMR - B/D 272-292 PDB
4EHQ X-ray 190 A G 69-88 PDB
AF-Q96D31-F1 Predicted AlphaFoldDB

311 variants for Q96D31

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV000173542
rs797044624
RCV001852111
1 M>L Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
rs1594204338
CA386980249
RCV000797946
2 H>Q Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs1594204339
RCV000820749
CA386980251
3 P>S Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV000890819
rs868908978
CA386980263
4 E>D Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
rs549883296
CA244608357
RCV001059022
RCV003130139
5 P>L Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
TOPMed
dbSNP
gnomAD
rs1356450700
CA386980283
RCV001206720
8 P>S Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA386980289
RCV001321337
rs868966101
9 P>S Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV001348094
rs1892784662
11 R>C Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
RCV000807612
RCV000994998
CA386980317
rs1290572755
13 S>C Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV001230575
rs1892784896
14 P>A Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
CA6837403
rs568054544
RCV000652300
17 P>S Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV001331514
rs1244560316
20 G>R Myopathy, tubular aggregate, 2 [ClinVar] Yes ClinVar
dbSNP
CA386980365
RCV001237483
rs1244560316
20 G>S Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
rs1273511135
RCV001317847
RCV002546055
CA386980427
25 S>R Inborn genetic diseases Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV000652298
rs1372064351
29 R>missing Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
RCV001236717
rs782013212
31 R>missing Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
rs782013212
RCV001230381
33 R>missing Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
RCV001323527
rs1465865018
CA386980519
33 R>H Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
RCV000652295
RCV001336793
rs781829024
CA6837408
RCV000836176
34 S>R Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001237591
rs1226204743
RCV000817881
CA386980583
CA386980581
38 E>D Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV000805745
rs781971569
38 E>missing Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
rs782531427
RCV000652294
CA6837415
39 P>A Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV003222180
rs782650611
RCV000966419
CA6837418
41 G>R Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs782427834
RCV001036772
CA386980792
42 A>S Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000923384
rs782427834
CA386980790
42 A>T Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001320973
rs782510098
46 P>missing Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
rs1892790744
RCV001220371
46 P>missing Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
RCV001317147
rs1892790617
46 P>missing Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
rs781855511
RCV000493887
CA244608430
RCV000763799
47 P>L Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1555322558
RCV000544520
48 S>missing Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
rs553962719
CA244608434
RCV001338226
51 T>I Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
dbSNP
gnomAD
RCV001343262
CA244608433
rs782810452
51 T>P Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV002524958
CA244608492
rs201617764
RCV000512761
61 S>P Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001344147
CA244608529
rs782424304
65 S>I Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000652297
CA386980976
rs1286173837
71 M>R Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
rs878853261
RCV000172858
88 A>missing Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
rs1892795100
RCV001206361
89 S>C Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
CA114898
VAR_026226
RCV000001346
rs118203993
91 R>W Combined immunodeficiency due to ORAI1 deficiency IMD9 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
rs1555322610
RCV000509049
CA386981209
97 S>C Myopathy, tubular aggregate, 2 Variant assessed as Somatic; impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
Ensembl
NCI-TCGA
dbSNP
VAR_078083
rs786204796
CA199185
RCV000169690
98 G>S Myopathy, tubular aggregate, 2 TAM2; constitutively active Ca(+2) channel, independently of STIM proteins; no effect on localization to the cell membrane [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
dbSNP
gnomAD
CA200154
rs786205890
RCV000172859
103 A>E Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
VAR_078084 107 V>M TAM2; constitutively active Ca(+2) channel, independently of STIM proteins; no effect on localization to the cell membrane [UniProt] Yes UniProt
CA6837472
RCV001231283
rs529121117
111 A>T Variant assessed as Somatic; 5.28e-05 impact. Combined immunodeficiency due to ORAI1 deficiency [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA6837475
RCV001056347
rs782316353
114 D>N Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV002269333
RCV001054287
rs1893050626
126 C>R Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
rs782478364
CA6837483
RCV001296348
132 A>G Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs786204797
RCV000169691
RCV003114320
CA199188
138 L>F Myopathy, tubular aggregate, 2 Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA6837490
rs782566002
RCV001336794
148 I>M Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA386983362
RCV001231972
CA386983364
rs1416832738
168 M>I Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA6837505
RCV001040774
rs559396531
170 R>C Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs1594212582
RCV000792445
182 I>missing Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
VAR_078085
rs1555324111
CA386983559
184 T>M TAM2; mediates excessive Ca(2+) entry when gated by STIM1; no effect on localization to the cell membrane [UniProt] Yes ClinGen
UniProt
dbSNP
gnomAD
RCV000172860
rs782753385
RCV002517660
CA200157
194 L>P Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001313530
rs782472239
CA6837529
211 P>H Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
VAR_038608
rs3741596
RCV000439937
RCV000553470
CA6837533
218 S>G Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA6837537
RCV000842445
RCV001089313
rs75603737
223 N>S Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs377456337
CA6837544
RCV001217587
228 G>S Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
dbSNP
gnomAD
CA386984202
rs1594212759
RCV000822319
234 A>T Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs782580422
CA6837550
RCV001300507
239 S>L Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV001221582
CA6837553
rs782656834
242 I>M Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000128581
rs587777528
VAR_071473
CA163352
245 P>L Myopathy, tubular aggregate, 2 TAM2; increases activation of the Ca2+ release-activated Ca2+ (CRAC) channel [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
CA6837565
rs781789915
RCV001212229
259 R>H Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA386984542
rs1555324156
RCV001246176
266 T>S Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
rs1311584085
RCV001065568
CA386984637
274 N>H Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
CA6837576
rs368440417
RCV001070162
275 E>K Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs368440417
RCV001055222
275 E>Q Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinVar
dbSNP
rs543436848
RCV001298465
CA6837578
277 A>V Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs1566472954
CA386984720
RCV000685546
282 L>* Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs1189464768
RCV001066327
CA386984825
292 H>N Combined immunodeficiency due to ORAI1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
CA386980265
rs1253665950
5 P>A No ClinGen
TOPMed
gnomAD
CA386980271
rs1450640152
6 A>S No ClinGen
TOPMed
CA386980282
rs1356450700
8 P>A No ClinGen
TOPMed
rs1555322475
CA386980292
9 P>L No ClinGen
gnomAD
rs1349225419
CA386980308
12 S>G No ClinGen
TOPMed
CA386980315
rs1290572755
13 S>R No ClinGen
TOPMed
gnomAD
rs1321846731
CA386980332
15 E>* No ClinGen
TOPMed
CA386980336
rs1388804322
15 E>D No ClinGen
TOPMed
CA386980344
rs1395306443
16 L>P No ClinGen
TOPMed
gnomAD
CA386980345
rs1395306443
16 L>R No ClinGen
TOPMed
gnomAD
CA386980356
rs1414126407
18 P>L No ClinGen
TOPMed
gnomAD
CA386980354
rs1414126407
18 P>Q No ClinGen
TOPMed
gnomAD
CA386980355
rs1414126407
18 P>R No ClinGen
TOPMed
gnomAD
CA386980367
rs1244560316
20 G>C No ClinGen
TOPMed
gnomAD
rs1451886623
CA386980373
21 G>C No ClinGen
TOPMed
gnomAD
CA386980374
rs1206335817
21 G>D No ClinGen
TOPMed
rs1451886623
CA386980372
21 G>R No ClinGen
TOPMed
gnomAD
rs1451886623
CA386980371
21 G>S No ClinGen
TOPMed
gnomAD
CA386980378
rs1555322490
22 S>C No ClinGen
TOPMed
CA386980379
rs1555322490
22 S>G No ClinGen
TOPMed
CA386980405
rs1555322493
24 T>I No ClinGen
gnomAD
CA386980400
rs1555322492
24 T>P No ClinGen
gnomAD
CA386980410
rs1344739416
25 S>R No ClinGen
TOPMed
gnomAD
CA386980436
rs1235655407
26 G>A No ClinGen
TOPMed
gnomAD
rs1555322494
CA386980429
26 G>S No ClinGen
gnomAD
CA386980442
rs1433032971
27 S>C No ClinGen
TOPMed
rs1390663869
CA386980446
27 S>R No ClinGen
TOPMed
CA386980455
rs1555322497
28 R>H No ClinGen
gnomAD
rs1413893402
CA386980464
29 R>W No ClinGen
TOPMed
gnomAD
CA386980487
rs1389191128
30 S>N No ClinGen
TOPMed
TCGA novel 33 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs782528899
CA6837409
35 G>E No ClinGen
ExAC
TOPMed
gnomAD
CA386980534
rs1555322508
35 G>R No ClinGen
gnomAD
rs1555322510
CA386980545
36 D>N No ClinGen
gnomAD
TCGA novel 36 D>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1276920059
CA386980551
36 D>V No ClinGen
TOPMed
CA386980564
rs1566465774
37 G>E No ClinGen
Ensembl
rs781905575
CA6837413
38 E>G No ClinGen
ExAC
TOPMed
gnomAD
rs782626197
CA6837412
38 E>K No ClinGen
ExAC
gnomAD
rs782531427
CA6837414
39 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs1555322519
CA386980600
40 P>L No ClinGen
gnomAD
CA6837416
rs782226648
40 P>S No ClinGen
ExAC
gnomAD
CA386980795
rs1212609439
42 A>V No ClinGen
TOPMed
CA244608417
rs1555322532
43 P>L No ClinGen
TOPMed
CA386980797
rs1594204610
43 P>T No ClinGen
Ensembl
rs782061638
CA386980811
45 P>L No ClinGen
ExAC
RCV001815348
rs375895928
RCV000596834
46 P>missing No ClinVar
dbSNP
rs782090818
CA244608426
46 P>S No ClinGen
ExAC
gnomAD
CA386980818
rs782786977
47 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs782786977
CA244608429
47 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA244608432
rs782168399
49 A>V No ClinGen
ExAC
TOPMed
gnomAD
RCV001731779
rs1555322554
51 T>missing No ClinVar
dbSNP
rs782718073
CA244608441
52 Y>H No ClinGen
ExAC
gnomAD
rs781872687
CA244608442
52 Y>S No ClinGen
ExAC
gnomAD
rs572379138
CA244608443
53 P>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA244608446
rs539709433
54 D>G No ClinGen
1000Genomes
ExAC
gnomAD
rs990333819
CA386980869
CA244608450
55 W>C No ClinGen
TOPMed
gnomAD
CA386980863
rs1555322563
55 W>R No ClinGen
gnomAD
CA244608458
rs782575915
56 I>V No ClinGen
ExAC
gnomAD
CA386980878
rs1412190366
57 G>S No ClinGen
TOPMed
CA244608462
rs370688474
57 G>V No ClinGen
ESP
TOPMed
gnomAD
rs782229951
CA386980882
58 Q>* No ClinGen
ExAC
TOPMed
CA244608469
rs782229951
58 Q>E No ClinGen
ExAC
TOPMed
CA386980887
rs1555322568
58 Q>H No ClinGen
gnomAD
CA386980884
rs1180527508
58 Q>R No ClinGen
TOPMed
CA684498656
rs1481710690
60 Y>* No ClinGen
TOPMed
gnomAD
CA244608487
rs782346907
60 Y>* No ClinGen
ExAC
gnomAD
rs1555322571
CA386980910
62 E>* No ClinGen
gnomAD
rs1594204758
CA386980921
63 V>G No ClinGen
Ensembl
rs1555322572
CA386980916
63 V>M No ClinGen
gnomAD
rs1320012911
CA386980926
64 M>T No ClinGen
TOPMed
gnomAD
CA386980923
rs1555322573
64 M>V No ClinGen
gnomAD
CA244608511
rs782424304
65 S>N No ClinGen
ExAC
TOPMed
gnomAD
rs782256310
CA244608496
65 S>R No ClinGen
ExAC
gnomAD
CA386980940
rs1555322575
66 L>P No ClinGen
gnomAD
rs557887137
CA244608548
67 N>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1555322579
CA386980945
67 N>S No ClinGen
gnomAD
CA386980959
rs1555322580
69 H>Y No ClinGen
gnomAD
CA386980966
rs1555322582
70 S>P No ClinGen
gnomAD
rs1555322585
CA386980972
71 M>V No ClinGen
gnomAD
CA244608555
rs782125665
72 Q>* No ClinGen
ExAC
gnomAD
rs1411464557
CA386980983
72 Q>R No ClinGen
TOPMed
gnomAD
rs782775454
CA244608560
73 A>V No ClinGen
ExAC
gnomAD
rs1373530893
CA386981001
75 S>C No ClinGen
TOPMed
CA386981002
rs1373530893
75 S>F No ClinGen
TOPMed
rs1555322589
CA386981009
76 W>C No ClinGen
gnomAD
rs781906725
CA244608565
76 W>R No ClinGen
ExAC
gnomAD
rs782528662
CA244608567
77 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA386981026
rs1555322590
79 L>F No ClinGen
gnomAD
CA244608568
rs782710707
80 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA386981033
rs782710707
80 Y>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 84 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA386981065
rs1555322599
85 K>E No ClinGen
gnomAD
rs782264993
CA6837422
85 K>T No ClinGen
ExAC
gnomAD
CA386981073
rs1555322600
86 L>F No ClinGen
gnomAD
CA386981078
rs1555322601
87 K>E No ClinGen
gnomAD
rs782283117
CA6837425
89 S>A No ClinGen
ExAC
gnomAD
CA386981187
rs1464356755
96 L>P No ClinGen
TOPMed
gnomAD
CA386981199
rs1555322609
97 S>P No ClinGen
gnomAD
rs1555322609
CA386981197
97 S>T No ClinGen
gnomAD
CA386981225
rs1317283235
98 G>D No ClinGen
TOPMed
CA386981217
rs786204796
98 G>R No ClinGen
gnomAD
CA6837468
rs782224950
103 A>T No ClinGen
ExAC
gnomAD
rs1341397217
CA386982844
104 M>T No ClinGen
TOPMed
CA386982841
rs1216488999
104 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA386982872
rs1594212388
107 V>G No ClinGen
Ensembl
CA386982878
rs1555324066
108 Q>* No ClinGen
gnomAD
rs782339337
CA6837469
109 L>V No ClinGen
ExAC
gnomAD
rs782654870
CA6837470
110 D>H No ClinGen
ExAC
gnomAD
rs529121117
CA386982901
111 A>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 113 H>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6837476
rs781973058
115 Y>N No ClinGen
ExAC
TOPMed
gnomAD
rs1172303142
CA386982941
116 P>L No ClinGen
TOPMed
CA6837477
rs782088694
117 P>L No ClinGen
ExAC
gnomAD
CA386982972
rs1555324077
122 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA6837480
rs782142903
125 A>S No ClinGen
ExAC
gnomAD
rs1475893363
CA386983013
128 T>P No ClinGen
TOPMed
gnomAD
rs368310115
CA6837486
137 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1566472555
CA386983111
143 C>Y No ClinGen
Ensembl
CA386983118
rs1555324089
144 I>L No ClinGen
gnomAD
CA386983123
rs1292892700
145 L>V No ClinGen
TOPMed
CA386983134
rs1555324091
147 N>D No ClinGen
gnomAD
CA6837488
rs782280709
147 N>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA6837489
rs782460502
148 I>V No ClinGen
ExAC
gnomAD
rs766782967
CA386983157
150 A>E No ClinGen
TOPMed
gnomAD
rs766782967
CA244616153
150 A>V No ClinGen
TOPMed
gnomAD
rs782291534
CA6837494
154 V>M No ClinGen
ExAC
rs1465923514
CA386983220
158 N>S No ClinGen
TOPMed
gnomAD
CA6837496
rs781929515
159 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs781948568
CA6837499
160 V>A No ClinGen
ExAC
gnomAD
rs1555324100
CA386983240
160 V>I No ClinGen
gnomAD
CA386983254
rs1162341529
161 K>Q No ClinGen
TOPMed
gnomAD
CA386983263
rs1594212509
161 K>R No ClinGen
Ensembl
TCGA novel 162 E>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA386983294
rs1594212518
163 S>F No ClinGen
Ensembl
rs1594212516
CA386983286
163 S>P No ClinGen
Ensembl
CA386983300
rs1555324101
164 P>S No ClinGen
gnomAD
TCGA novel 165 H>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1462694448
CA386983325
166 E>K No ClinGen
TOPMed
rs782538669
CA6837503
167 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs782716897
CA6837504
167 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs1555324103
CA386983352
168 M>V No ClinGen
Ensembl
CA386983377
rs1555324104
169 H>L No ClinGen
gnomAD
CA386983373
rs1555324104
169 H>P No ClinGen
gnomAD
TCGA novel 170 R>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1555324106
CA386983402
171 H>R No ClinGen
gnomAD
rs533220170
CA6837506
173 E>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA6837508
rs782263269
176 W>C No ClinGen
ExAC
gnomAD
rs782615527
CA6837507
176 W>R No ClinGen
ExAC
gnomAD
CA386983501
rs1272954395
180 T>N No ClinGen
TOPMed
CA386983498
rs1594212559
180 T>P No ClinGen
Ensembl
CA6837510
rs782652213
181 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs782652213
CA386983512
181 V>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 182 I>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs3741595
CA6837513
182 I>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs782193559
CA6837511
182 I>T No ClinGen
ExAC
gnomAD
rs1266070960
CA386983523
182 I>V No ClinGen
TOPMed
gnomAD
rs782383265
CA6837515
186 L>F No ClinGen
ExAC
gnomAD
CA6837517
rs782162606
187 F>I No ClinGen
ExAC
gnomAD
CA386983611
rs1369884389
187 F>S No ClinGen
TOPMed
CA386983642
rs1442588212
189 A>P No ClinGen
TOPMed
CA386983656
rs1555324116
190 E>Q No ClinGen
gnomAD
CA386983756
rs1555324118
195 C>S No ClinGen
gnomAD
rs781831596
CA6837522
198 K>E No ClinGen
ExAC
gnomAD
CA6837523
rs371339953
200 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1555324120
CA386983855
200 L>S No ClinGen
gnomAD
TCGA novel 202 L>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs782798667
CA6837524
203 K>R No ClinGen
ExAC
rs1555324122
CA386983931
205 Q>H No ClinGen
gnomAD
CA386983946
rs1555324123
207 G>D No ClinGen
gnomAD
CA6837527
rs549114021
207 G>S No ClinGen
1000Genomes
ExAC
gnomAD
CA386983973
rs1555324125
209 P>L No ClinGen
gnomAD
CA386983975
rs1440863247
210 R>G No ClinGen
TOPMed
CA244616420
rs529514669
211 P>S No ClinGen
gnomAD
CA244616443
rs371645148
212 T>S No ClinGen
ESP
rs1252712174
CA386984007
213 S>G No ClinGen
TOPMed
gnomAD
CA386984028
rs1555324127
214 K>N No ClinGen
Ensembl
TCGA novel 215 P>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6837530
rs782647571
215 P>L No ClinGen
ExAC
gnomAD
rs1555324131
CA386984047
216 P>L No ClinGen
gnomAD
CA386984045
rs1555324131
216 P>R No ClinGen
gnomAD
CA6837532
rs782438034
217 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs782194424
CA6837534
218 S>R No ClinGen
ExAC
gnomAD
CA6837536
rs781972261
220 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA244616491
rs782420247
221 A>V No ClinGen
TOPMed
rs75603737
CA6837539
223 N>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs75603737
CA6837538
223 N>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs782722476
CA6837541
224 V>F No ClinGen
ExAC
TOPMed
gnomAD
CA386984116
rs782722476
224 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs372746781
CA6837542
226 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs372746781
CA386984132
226 T>N No ClinGen
ExAC
TOPMed
gnomAD
CA244616597
rs1028254331
228 G>A No ClinGen
Ensembl
CA386984162
rs1555324138
230 T>S No ClinGen
gnomAD
CA6837545
rs369586125
231 P>L No ClinGen
ESP
ExAC
gnomAD
rs1566472809
CA386984170
231 P>S No ClinGen
Ensembl
CA386984206
rs1555324140
234 A>V No ClinGen
gnomAD
rs1555324141
CA386984217
235 A>V No ClinGen
gnomAD
CA386984232
rs1298307750
237 I>V No ClinGen
TOPMed
gnomAD
rs782448303
CA6837549
238 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1594212784
CA386984257
240 T>P No ClinGen
Ensembl
rs1394978626
CA386984267
241 T>A No ClinGen
TOPMed
rs1555324147
CA386984280
242 I>T No ClinGen
gnomAD
rs1555324148
CA386984285
243 M>V No ClinGen
gnomAD
CA6837556
rs782401288
246 F>L No ClinGen
ExAC
TOPMed
gnomAD
CA244616737
rs957548015
246 F>Y No ClinGen
Ensembl
CA6837557
rs782169524
247 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA386984343
rs1555324151
248 L>V No ClinGen
gnomAD
rs1485414099
CA386984385
252 V>I No ClinGen
TOPMed
gnomAD
CA6837560
rs374711919
254 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA6837562
rs376286032
255 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1555324153
CA386984457
258 Y>C No ClinGen
gnomAD
CA6837564
rs782717492
259 R>S No ClinGen
ExAC
gnomAD
rs782689571
CA6837570
262 V>I No ClinGen
ExAC
gnomAD
TCGA novel 263 S>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA386984527
rs1555324155
265 K>E No ClinGen
gnomAD
rs782794556
CA386984550
267 D>H No ClinGen
ExAC
gnomAD
CA6837573
rs782794556
267 D>N No ClinGen
ExAC
gnomAD
CA386984564
rs1555324160
268 R>* No ClinGen
gnomAD
rs1555324161
CA386984566
268 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 272 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs782201078
CA6837574
274 N>K No ClinGen
ExAC
gnomAD
CA6837577
rs782293603
277 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA386984690
rs1594212895
279 F>V No ClinGen
Ensembl
CA386984711
rs1426012800
281 R>C No ClinGen
TOPMed
gnomAD
rs1555324166
CA386984713
281 R>H No ClinGen
gnomAD
rs782746490
CA6837581
285 Q>* No ClinGen
ExAC
gnomAD
CA386984768
rs1555324169
286 L>Q No ClinGen
gnomAD
CA386984771
rs1555324169
286 L>R No ClinGen
gnomAD
CA386984776
rs1555324170
287 D>H No ClinGen
gnomAD
rs1555324173
CA386984792
288 H>Q No ClinGen
gnomAD
CA386984786
rs1474919531
288 H>Y No ClinGen
TOPMed
CA6837582
rs781960958
291 D>H No ClinGen
ExAC
TOPMed
gnomAD
rs1555324176
CA386984830
292 H>P No ClinGen
gnomAD
CA6837584
rs782134309
292 H>Q No ClinGen
ExAC
rs1555324177
CA386984838
293 P>S No ClinGen
gnomAD
rs555170508
CA6837585
295 T>M Variant assessed as Somatic; 5.749e-05 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA6837589
rs781835452
297 G>A No ClinGen
ExAC
gnomAD
CA386984871
rs375464035
297 G>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs375464035
CA6837588
297 G>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA244616957
rs1018909095
299 H>R No ClinGen
TOPMed
gnomAD
CA6837592
rs781854510
300 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs782639925
CA6837591
300 Y>D No ClinGen
ExAC
gnomAD

2 associated diseases with Q96D31

[MIM: 612782]: Immunodeficiency 9 (IMD9)

An immune disorder characterized by recurrent infections, impaired activation and proliferative response of T-cells, decreased T-cell production of cytokines, and normal lymphocytes counts and serum immunoglobulin levels. In surviving patients ectodermal dysplasia with anhidrosis and non-progressive myopathy may be observed. {ECO:0000269|PubMed:16147976, ECO:0000269|PubMed:16582901}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 615883]: Myopathy, tubular aggregate, 2 (TAM2)

A rare congenital myopathy characterized by regular arrays of membrane tubules on muscle biopsies without additional histopathological hallmarks. Tubular aggregates in muscle are structures of variable appearance consisting of an outer tubule containing either one or more microtubule-like structures or amorphous material. TAM2 patients have myopathy and pupillary abnormalities. {ECO:0000269|PubMed:24591628, ECO:0000269|PubMed:28058752}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • An immune disorder characterized by recurrent infections, impaired activation and proliferative response of T-cells, decreased T-cell production of cytokines, and normal lymphocytes counts and serum immunoglobulin levels. In surviving patients ectodermal dysplasia with anhidrosis and non-progressive myopathy may be observed. {ECO:0000269|PubMed:16147976, ECO:0000269|PubMed:16582901}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • A rare congenital myopathy characterized by regular arrays of membrane tubules on muscle biopsies without additional histopathological hallmarks. Tubular aggregates in muscle are structures of variable appearance consisting of an outer tubule containing either one or more microtubule-like structures or amorphous material. TAM2 patients have myopathy and pupillary abnormalities. {ECO:0000269|PubMed:24591628, ECO:0000269|PubMed:28058752}. Note=The disease is caused by variants affecting the gene represented in this entry.

No regional properties for Q96D31

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q96D31

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
  • Basolateral cell membrane ; Multi-pass membrane protein
  • Upon store depletion, colocalizes with STIM1 in membrane punctae at ER-PM junctions (PubMed:19182790, PubMed:19249086, PubMed:26221052, PubMed:27185316)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
basolateral plasma membrane The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
calcium channel complex An ion channel complex through which calcium ions pass.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
membrane raft Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
plasma membrane raft A membrane raft that is part of the plasma membrane.

4 GO annotations of molecular function

Name Definition
calcium channel activity Enables the facilitated diffusion of a calcium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.
calmodulin binding Binding to calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states.
identical protein binding Binding to an identical protein or proteins.
store-operated calcium channel activity A ligand-gated ion channel activity which transports calcium in response to emptying of intracellular calcium stores.

8 GO annotations of biological process

Name Definition
adaptive immune response An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
calcium ion import The directed movement of calcium ions into a cell or organelle.
calcium ion transmembrane transport A process in which a calcium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
mammary gland epithelium development The process whose specific outcome is the progression of the mammary gland epithelium over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
positive regulation of adenylate cyclase activity Any process that activates or increases the frequency, rate or extent of adenylate cyclase activity.
positive regulation of calcium ion transport Any process that activates or increases the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
regulation of calcium ion transport Any process that modulates the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
store-operated calcium entry A calcium ion entry mechanism in the plasma membrane activated by the depletion of calcium ion from the internal calcium ion store in the endoplasmic reticulum.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q96SN7 ORAI2 Protein orai-2 Homo sapiens (Human) PR
Q8BH10 Orai2 Protein orai-2 Mus musculus (Mouse) PR
Q8BWG9 Orai1 Calcium release-activated calcium channel protein 1 Mus musculus (Mouse) PR
Q5M848 Orai1 Calcium release-activated calcium channel protein 1 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MHPEPAPPPS RSSPELPPSG GSTTSGSRRS RRRSGDGEPP GAPPPPPSAV TYPDWIGQSY
70 80 90 100 110 120
SEVMSLNEHS MQALSWRKLY LSRAKLKASS RTSALLSGFA MVAMVEVQLD ADHDYPPGLL
130 140 150 160 170 180
IAFSACTTVL VAVHLFALMI STCILPNIEA VSNVHNLNSV KESPHERMHR HIELAWAFST
190 200 210 220 230 240
VIGTLLFLAE VVLLCWVKFL PLKKQPGQPR PTSKPPASGA AANVSTSGIT PGQAAAIAST
250 260 270 280 290 300
TIMVPFGLIF IVFAVHFYRS LVSHKTDRQF QELNELAEFA RLQDQLDHRG DHPLTPGSHY
A